Global equities traded higher, with the
US continuing to lead other developed
markets (the US up +8.5% vs. Europe +6.4%
over 2Q). The FOMC shifted its guidance
in a slightly hawkish direction mid-month.
May 2021 CPI reports highlighted the
sharp and broad-based acceleration in
global inflation. In the first 6 months
of CY2021, global growth was strong,
but gains were uneven across regions,
owing to variations in policy support and
vaccination programs. Growth leadership
has shifted to the US, which is booming
on the back of full-bodied monetary and
fiscal stimulus, and away from China,
where fiscal and credit tightening slowed
growth below trend.
The upbeat macro backdrop, strong consumer spending outlook, and widening gap between strength
in earnings and stalling price relatives portend further equity upside and outperformance of Cyclicals vs
Defensives.
Federal Reserve (Fed) heading into early normalization, starting with QE (quantitative easing)
rollback: The FOMC's (Federal Open Market Committee) advancement of rate lift-off to 2023 with two
rate hikes is an acknowledgment that its macro-economic goals are being met sooner than anticipated.
The estimated Fed rate fair value is 0.20-0.25%. It has been above 0% since Jan'21 or in just 7 months after
the Covid-19 shock, much sooner than the 36 months it took after the 2008 GFC (global financial crisis)
Covid & Vaccines:
India's second Covid-19 wave peaked and rolled over in early May, with new cases
now trending down to 47k. The 7DMA of vaccine shots administered has increased sharply from under
2mn a day in the middle of May to over 5.7mn now. As of 30 June, ~20% of the population has taken at
least one shot). Urban locations (districts with at least 60% urban population) have administered at least
one shot to 1/4th of their people, while non-urban is at 14%. This means reopening (urban services) can
happen sooner. The vaccination pace is expected to increase with the announcement of free vaccines for
all above the age of 18 years at the cost of the Centre.